These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 17023807)

  • 21. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
    Devogelaer JP; Sambrook P; Reid DM; Goemaere S; Ish-Shalom S; Collette J; Su G; Bucci-Rechtweg C; Papanastasiou P; Reginster JY
    Rheumatology (Oxford); 2013 Jun; 52(6):1058-69. PubMed ID: 23365149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
    Talbot JC; Elener C; Praveen P; Shaw DL
    Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic therapy for the treatment and prevention of osteoporosis.
    McClung B; McClung M
    Nurs Clin North Am; 2001 Sep; 36(3):433-40, viii. PubMed ID: 11532658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen deprivation in veterans with prostate cancer: implications for skeletal health.
    Wilcox A; Carnes ML; Moon TD; Tobias R; Baade H; Stamos E; Elliott ME
    Ann Pharmacother; 2006 Dec; 40(12):2107-14. PubMed ID: 17132807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ; Zacharin MR
    J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
    Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M;
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
    Hasegawa M; Nisikawa M; Nomura S; Takubo T; Suehiro A; Saigo K; Hayashi K; Tamaki S; Mizutani M; Uemura Y; Kurata Y;
    Rinsho Ketsueki; 2005 Feb; 46(2):121-6. PubMed ID: 16447705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.
    Bhoopalam N; Campbell SC; Moritz T; Broderick WR; Iyer P; Arcenas AG; Van Veldhuizen PJ; Friedman N; Reda D; Warren S; Garewal H
    J Urol; 2009 Nov; 182(5):2257-64. PubMed ID: 19758618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F; Borges JL; Curiel MD
    Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.